PAB.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 01:29):

Stats
Today's Volume	2.05M
Average Volume	1.09M
Market Cap	18.52M
EPS	$0 ( 2024-02-22 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Patrys Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Patrys Ltd Financials

Annual	2023
Revenue:	$2.85M
Gross Profit:	$2.80M (98.35 %)
EPS:	$-0.00340

Q2	2024
Revenue:	$669 434
Gross Profit:	$669 434 (100.00 %)
EPS:	$-0.00100

Q4	2023
Revenue:	$1.03M
Gross Profit:	$1.03M (100.00 %)
EPS:	$-0.00150

Q3	2022
Revenue:	$512 955
Gross Profit:	$512 955 (100.00 %)
EPS:	$-0.000800

Financial Reports:

No articles found.

Patrys Ltd

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates cell nuclei. The company also focuses on developing PAT-DX1, an antibody fragment for the treatment of primary and secondary brain cancer. In addition, it is developing PAT-DX3, a full-sized antibody that has DNA-binding and DNA damage repair blocking properties of PAT-DX1 used for tissue distribution, pharmacokinetic profile, etc.; and PAT-DX1-NP, a product based on the targeted delivery of nanoparticles carrying therapeutic payloads to the inside of cancer cells. The company was incorporated in 2006 and is based in Melbourne, Australia.